贝瑞基因：第三季度净利润-2532.12万元，同比下降2355.45%

Core Viewpoint - Berry Genomics (000710) reported a significant decline in both revenue and net profit for Q3 2025, indicating potential challenges in its business operations [1] Financial Performance - The company achieved a revenue of 238 million yuan in Q3 2025, representing a year-on-year decrease of 12.06% [1] - The net profit for the same period was -25.32 million yuan, reflecting a substantial year-on-year decline of 2355.45% [1]